In the absence of any PR from GSK, BTA management could be talking up the advantages of Relenza over Tamiflu a bit more too , citing NEJM and comments from other leading independent scientists and experts.
must admit I'm getting a bit fed up too with their lack of engagement with the media or market.
ps what exactly did the Aus. of the year say about Relenza ?
aussie of year applauds relenza, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)